Patents by Inventor John J. Foster

John J. Foster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intrathecal baclofen pharmaceutical dosage forms and related delivery system
    Patent number: 11147926
    Abstract: According to the subject invention, there is disclosed, a dosage and packaging configuration which includes the use of color-coded pre-filled syringes and vials to fill and refill infusion systems with existing and new dosage forms of intrathecal baclofen.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: October 19, 2021
    Assignee: PIRAMAL CRITICAL CARE, INC.
    Inventors: John J. Foster, Thomas R. Prentice
  • Intrathecal hydromorphone solutions having improved stability
    Patent number: 10905685
    Abstract: The present disclosure relates generally to a pharmaceutical solution comprising hydromorphone or a pharmaceutically acceptable salt thereof that is substantially free of buffer and optionally one or more other additives. The pharmaceutically acceptable salt may be hydromorphone hydrochloride. Also disclosed are methods for the manufacture and use of the solution.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: February 2, 2021
    Assignee: Piramal Critical Care, Inc.
    Inventors: John J. Foster, Thomas R. Prentice
  • INTRATHECAL BACLOFEN PHARMACEUTICAL DOSAGE FORMS AND RELATED DELIVERY SYSTEM
    Publication number: 20160151575
    Abstract: According to the subject invention, there is disclosed, a dosage and packaging configuration which includes the use of color-coded pre-filled syringes and vials to fill and refill infusion systems with existing and new dosage forms of intrathecal baclofen.
    Type: Application
    Filed: February 3, 2016
    Publication date: June 2, 2016
    Inventors: John J. Foster, Thomas R. Prentice
  • STABILITY OF HYDROMORPHONE HYDROCHLORIDE SOLUTIONS
    Publication number: 20150359790
    Abstract: The present invention relates generally to a sterile hydromorphone hydrochloride solution that is substantially free of buffer.
    Type: Application
    Filed: August 25, 2015
    Publication date: December 17, 2015
    Inventors: John J. Foster, Thomas R. Prentice
  • Stability of hydromorphone hydrochloride solutions
    Patent number: 9155734
    Abstract: The present invention relates generally to a sterile hydromorphone hydrochloride solution that is substantially free of buffer.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: October 13, 2015
    Assignee: Mallinckrodt LLC
    Inventors: John J. Foster, Thomas R. Prentice
  • INTRATHECAL BACLOFEN PHARMACEUTICAL DOSAGE FORMS AND RELATED DELIVERY SYSTEM
    Publication number: 20150258279
    Abstract: According to the subject invention, there is disclosed, a dosage and packaging configuration which includes the use of color-coded pre-filled syringes and vials to fill and refill infusion systems with existing and new dosage forms of intrathecal baclofen.
    Type: Application
    Filed: May 29, 2015
    Publication date: September 17, 2015
    Inventors: John J. Foster, Thomas R. Prentice, Angela S. Strantz
  • INTRATHECAL BACLOFEN PHARMACEUTICAL DOSAGE FORMS WITH FEWER DEGRADATION PRODUCTS
    Publication number: 20150105466
    Abstract: The present invention relates generally to a sterile, particulate-free, stable intrathecal baclofen solution with less than 0.5% of 4-(4-chlorophenyl)-2-pyrrolidone, a degradation product. These solutions are stable under a variety of storage conditions and for extended periods of time. Also disclosed are methods for preparing such compositions.
    Type: Application
    Filed: December 18, 2014
    Publication date: April 16, 2015
    Inventors: John J. Foster, Angela A. Strantz
  • Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
    Patent number: 8969414
    Abstract: The present invention relates generally to a sterile, particulate-free, stable intrathecal baclofen solution with less than 0.5% 4-(4-chlorophenyl)-2-pyrrolidone, a degradation product. These solutions are stable under a variety of storage conditions and for extended periods of time. Also disclosed are methods for preparing such compositions.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: March 3, 2015
    Assignee: Mallinckrodt LLC
    Inventors: John J. Foster, Angela S. Strantz
  • INTRATHECAL HYDROMORPHONE SOLUTIONS HAVING IMPROVED STABILITY
    Publication number: 20140005219
    Abstract: The present disclosure relates generally to a pharmaceutical solution comprising hydromorphone or a pharmaceutically acceptable salt thereof that is substantially free of buffer and optionally one or more other additives. The pharmaceutically acceptable salt may be hydromorphone hydrochloride. Also disclosed are methods for the manufacture and use of the solution.
    Type: Application
    Filed: September 6, 2013
    Publication date: January 2, 2014
    Inventors: John J. Foster, Thomas R. Prentice
  • Stability of Hydromorphone Hydrochloride Solutions
    Publication number: 20130237558
    Abstract: The present invention relates generally to a sterile hydromorphone hydrochloride solution that is substantially free of buffer.
    Type: Application
    Filed: March 6, 2013
    Publication date: September 12, 2013
    Applicant: Mallinckrodt LLC
    Inventors: John J. Foster, Thomas R. Prentice
  • INTRATHECAL BACLOFEN PHARMACEUTICAL DOSAGE FORMS AND RELATED DELIVERY SYSTEM
    Publication number: 20110269836
    Abstract: According to the subject invention, there is disclosed, a dosage and packaging configuration which includes the use of color-coded pre-filled syringes and vials to fill and refill infusion systems with existing and new dosage forms of intrathecal baclofen.
    Type: Application
    Filed: March 12, 2009
    Publication date: November 3, 2011
    Applicant: CNS Therapeutics, Inc.
    Inventors: John J. Foster, Thomas R. Prentice
  • INTRATHECAL BACLOFEN PHARMACEUTICAL DOSAGE FORMS WITH FEWER DEGRADATION PRODUCTS
    Publication number: 20100216887
    Abstract: The present invention relates generally to a sterile, particulate-free, stable intrathecal baclofen solution with less than 0.5% 4-(4-chlorophenyl)-2-pyrrolidone, a degradation product. These solutions are stable under a variety of storage conditions and for extended periods of time. Also disclosed are methods for preparing such compositions.
    Type: Application
    Filed: February 5, 2010
    Publication date: August 26, 2010
    Applicant: CNS THERAPEUTICS, INC.
    Inventors: John J. Foster, Angela S. Strantz